“The broader vision and mission of our study is to develop a minimally invasive blood test kit for early diagnostics, monitoring, and guiding therapeutic planning of triple-negative breast cancer patients.”
Scientists Identify Novel Molecular Biomarkers in Cells That
Breast cancer biomarkers, and a new clinical category for HER2
Researchers Identify Potential Target for Rhabdomyosarcoma
Ajay P. Singh, Ph.D.
Machine learning assisted analysis of breast cancer gene
Cancers, Free Full-Text
Seema Singh, Ph.D.
Noninvasive Biomarkers: Emerging Trends in Early Detection of
Biomedicines, Free Full-Text
Med School Watercooler: 2023
The subtypes of triple negative breast cancer.
Seema Singh, Ph.D.
Breast Cancer Research Foundation of Alabama (@BCRFAlabama) / X